Background
==========

The medical literature is an integral component of clinical care, education, and research, as it has a serious impact on our understanding of health and disease. There are thousands of medical journals that publish articles related to clinical interventions, prognosis, diagnosis, and risks -- among others -- with an influence on health and life in general. For example, a quick glance at PubMed shows over 22 million citations for biomedical literature.[@b1-jmdh-6-169] It is therefore a challenge to try to assimilate data presented in the literature and make evidence-based informed decisions. Attempts to summarize these data using systematic reviews are commendable as these reviews aim to provide a summary of the state of knowledge on a specific topic and address the inconsistent findings from single studies. However, these reviews are exponential in number and may report disparate findings. Searching for systematic reviews on depression resulted in 30,038 articles,[@b2-jmdh-6-169] and in cancer resulted in 323,633.[@b3-jmdh-6-169]

One way to assimilate and disseminate knowledge that can influence decision-making and provide an understanding of a certain condition is to perform a systematic review of reviews. The past few decades have given rise to a handful of such studies in several clinical areas including lifestyle interventions,[@b4-jmdh-6-169] interventions to improve mental health,[@b5-jmdh-6-169] homeopathy,[@b6-jmdh-6-169] medical education,[@b7-jmdh-6-169] spinal manipulation,[@b8-jmdh-6-169] sleep medicine,[@b9-jmdh-6-169] and cancer,[@b10-jmdh-6-169] among others. Each of these reviews of reviews is focused on a specific clinical question. There is a paucity of systematic reviews that assess the quality of reporting of clinical studies across different clinical areas, and that use different reporting guidelines. The EQUATOR (Enhancing Quality and Transparency in Health Research) network is an international initiative that supports the development and dissemination of such guidelines.[@b11-jmdh-6-169] The EQUATOR website provides guidelines for the minimum information required to report research methods and findings for various kinds of medical research.[@b12-jmdh-6-169]

The evidence that is presented in the clinical literature can carry substantial weight in informing professionals and users of health care on multiple aspects of health risks, disease, health care outcomes, and delivery. However, readers of the literature are faced with conflicting results presented in various formats and styles, making interpretations and conclusions challenging even for the most informed readers. For this reason, a consensus on reporting such evidence is needed to establish the quality of such studies. It is also important to ensure that a more uniform method is used by researchers to enable the combination of results from multiple studies and reach more standardized summaries and conclusions; this can minimize heterogeneity, which often complicates meta-analyses in future studies. Furthermore, poorly reported research can cause harm to patients and lead to the use of scarce resources on ineffective treatments.[@b13-jmdh-6-169]

To address the concern over the quality of reported studies and ensure transparency in reporting clinical studies, the Consolidated Standards of Reporting Trials (CONSORT)[@b14-jmdh-6-169] statement was produced as a collaborative effort to provide a checklist and flow diagram for authors to have as a guide to prepare reports on randomized controlled trials (RCTs) for publication. The CONSORT Statement was further updated in 2010 based on new evidence and an added focus on specific designs of RCTs.[@b15-jmdh-6-169] The CONSORT is a widely accepted and adopted statement that is well described in many freely accessible publications and websites. In brief, the CONSORT Statement provides a 25-item checklist describing the required criteria for inclusion when reporting RCTs. Such items include the study design, the participants, interventions, outcomes, and sample size among others. It also recommends the inclusion of a flow diagram, accounting for recruitment, randomization, allocation of interventions, and retention in the study.[@b16-jmdh-6-169] Since the introduction of the CONSORT, several extensions and modifications of the original statement have been established to improve the quality of reporting of various study types, including observational studies, systematic reviews, and meta-analysis. Despite the availability of such guidelines for reporting, the quality of reporting of clinical studies has remained suboptimal with several manuscripts in a number of clinical areas missing key items as described in the CONSORT.[@b16-jmdh-6-169]--[@b23-jmdh-6-169]

Evidence suggests that the use of the CONSORT criteria is associated with improved standards of reporting.[@b24-jmdh-6-169],[@b25-jmdh-6-169] However, it is not clear what the current level of adherence to reporting guidelines is, what factors are associated with improving the reporting of clinical literature, and how the results from different studies on reporting standards can be compiled to provide an overall conclusion on the current state of reporting standards.

We therefore undertook a systematic scoping review evaluating systematic reviews addressing the adherence standards to reporting guidelines published since the introduction of the CONSORT Statement in January 1996 to September 2012.

Study aims
----------

In this study, we aimed to examine the extent of adherence to reporting guidelines in published clinical research since the introduction of the CONSORT Statement in 1996. The purpose of this systematic scoping review is to inform researchers, guideline developers, journal editors, and evidence users on the profile of reporting the existing literature and the current state of knowledge in the application of these guidelines. In particular, we will endeavor to address the following questions: (1) what is the current adherence to the reporting standards that include the CONSORT,[@b26-jmdh-6-169] Strengthening the Reporting of Observational Studies in Epidemiology (STROBE),[@b27-jmdh-6-169] Quality of Reporting of Meta-analysis -- (QUOROM),[@b28-jmdh-6-169] Transparent Reporting of Evaluations with Nonrandomized Designs (TREND),[@b29-jmdh-6-169] Meta-analysis Of Observational Studies in Epidemiology (MOOSE),[@b30-jmdh-6-169] and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines?[@b31-jmdh-6-169] (2) What are the factors that are associated with adherence to reporting standards in medical literature? And (3) what guidance can we provide based on the current state of knowledge on adherence to reporting standards? More specifically the objectives of this review are to:

1.  Report the levels of adherence to the above reporting guidelines in clinical research;

2.  Determine the key factors associated with adherence to good reporting; and

3.  Provide recommendations to enhance adherence to reporting guidelines for future studies.

We preselected the six guidelines above because they are among the oldest and the most popular, spanning through a wide range of study designs and clinical areas, and are therefore likely to be reported in systematic reviews, thus potentially generating a number of reviews to be included in this study.

Methods
=======

We adopted a "systematic" scoping review approach -- which is a combination of a scoping review methodology -- to ensure the inclusion of broad areas of research and study designs, and a systematic review of reviews methodology.[@b32-jmdh-6-169],[@b33-jmdh-6-169]

A scoping review is a relatively new type of study providing an assessment of available evidence from the literature in a broad area of research such as the compliance in the reporting of clinical studies to established guidelines. It also serves to identify gaps in the field and provide recommendations for implementation.[@b32-jmdh-6-169] The methodology of scoping reviews was first described in detail by Arksey and O'Malley[@b32-jmdh-6-169] in their pivotal paper published in 2005, which provided a foundation for carrying out a scoping review. This framework was further operationalized, and five stages were proposed to be followed when conducting a scoping review, including: (1) the identification of a research question; (2) finding the relevant studies; (3) the selection of studies to be included in the review; (4) data extraction from the included studies; and (5) assembling, summarizing, and reporting the results of the review.[@b34-jmdh-6-169]

The methods of conducting a systematic review of systematic reviews follow a similar approach, but include the provision of guidelines and suggestions for clinical practice, education, and research.[@b33-jmdh-6-169] The aim of the methods and search strategy here is to ensure that the systematic review of reviews is comprehensive, thorough, and objective. We will report the results using the PRISMA (formerly QUOROM) reporting guidelines for systematic reviews.[@b35-jmdh-6-169] A protocol was specifically designed for this study outlining the study design, search strategy, and selection criteria.

Data sources and search strategy
--------------------------------

Electronic literature databases including Cumulative Index to Nursing and Allied Health Literature (CINAHL), Web of Science, Embase, and Medline (from January 1996 \[date of CONSORT\] to September 2012) were searched using a comprehensive search strategy designed with the assistance of a librarian who is experienced in conducting systematic reviews. The reference lists of identified articles were also reviewed for additional studies, and a manual search of key journals like BioMed Central systematic reviews, BioMed Central Research Methodology, and the Cochrane Library was conducted to avoid missing relevant reviews. Such search strategies are well supported for this type of systematic search and retrieval of relevant studies.[@b36-jmdh-6-169],[@b37-jmdh-6-169] The databases were searched for the following key search terms: (Systematic reviews OR reviews OR quality of reporting OR completeness of reporting) AND (CONSORT OR STROBE OR QUOROM OR QUORUM OR PRISMA OR TREND OR MOOSE) OR adherence. For Web of Science, we also performed a forward citation search of the publications pertaining to reporting guidelines, whose acronyms might have other meanings, such as TREND and QUORUM. This helped us to decrease the occurrence of false positives in our search.

Initially, no language limits were set to identify the number of non-English reviews; however, a limit was then set for English language reviews only (which was necessary due to the lack of resources required to translate reviews from other languages). We also set the limits to "human" and "published complete systematic reviews."

Inclusion criteria
------------------

1.  Systematic reviews of clinical studies addressing the quality of reporting of the studies based on at least one of the six preselected reporting guidelines: CONSORT for RCTs; TREND for non-RCTs; STROBE for observational studies; and PRISMA (formerly QUOROM) or MOOSE for systematic reviews of RCTs or observational studies, respectively.

2.  The systematic reviews must be complete (not abstracts only), reported in English, and investigating the quality of reporting in human studies of all age groups using one of the above guidelines.

3.  The quality of reporting guidelines must be the primary focus of the systematic review.

Exclusion criteria
------------------

Systematic reviews were excluded if they were published as abstract only; the primary focus of the review was not on the quality of reporting; the quality of reporting was based on the standards of reporting that were different from the ones stated above, or if they were a duplicate publication of existing reviews (commentaries, letters, and editorials).

Selection of systematic reviews
-------------------------------

Two independent reviewers examined the titles and abstracts of all citations identified in the literature search. Articles were selected for full-text review if the inclusion criteria were met and if both reviewers considered the citation potentially relevant. Disagreement at any stage of study selection was resolved by discussion and consensus between the two reviewers. If agreement could not be reached a third author was recruited to determine eligibility. Initial agreement between the two reviewers was calculated using the kappa statistic.[@b38-jmdh-6-169]

Each reviewer independently:

-   Assessed retrieved titles and abstracts for relevance and duplication;

-   Screened full text articles deemed eligible for inclusion;

-   Decided on including or excluding articles;

-   Extracted relevant data using specifically designed data abstraction forms;

-   Appraised the quality of the included reviews. A PRISMA flow diagram of included/excluded studies is provided ([Figure 1](#f1-jmdh-6-169){ref-type="fig"}).[@b35-jmdh-6-169]

Quality assessment of systematic reviews
----------------------------------------

The quality of each systematic review that met the inclusion criteria for the study was assessed using a modified version of the assessment of multiple systematic reviews (AMSTAR, a validated tool to assess the methodological quality of systematic reviews).[@b39-jmdh-6-169]--[@b41-jmdh-6-169] Certain items of AMSTAR are not relevant to this type of review and cannot be assessed (eg, item 9, "Were the methods used to combine the findings of studies appropriate?"), as pooling of data may not be feasible in all systematic reviews of methodological quality, and should relate to the study question. In addition, item 10 ("Was the likelihood of publication bias assessed?") is irrelevant to this review, which is focused on the quality of reporting of published studies. Both of these items were omitted from the quality assessment.

We also used the modified version of the enhanced Overview Quality Assessment Questionnaire (OQAQ) to assess the quality of systematic reviews included in this study.[@b42-jmdh-6-169] In addition to these tools, we assessed the quality of the reviews based on the following criteria: the use of explicit criteria to assess individual study quality using the guidelines checklist; explicit definition of the research question using a flow diagram to explain study selection; and a formal sample size calculation for the assessment of association.

Data abstraction
----------------

A spreadsheet was created to record the following items from the selected reviews: authors, year of publication, number of primary studies included in the review, study location, study type, primary outcomes of the study, outcomes measures, and the overall results and conclusions. Two authors independently piloted the data extraction form for this review and modifications were made when necessary before reaching the final data abstraction forms used for this study. Data abstraction disagreements were resolved by discussion and consensus, and a third author extracted the data if an agreement could not be reached. Data collected from each systematic review included the study primary question, primary outcome, number of the studies included in the review, the statement investigated, quality assessment, the factors associated with adherence, the journal of publication, and whether the journal endorsed the statement in question.

Analysis
--------

The level of agreement between raters was estimated using the kappa statistic. The adherence to reporting standards was summarized, and key determinants of adherence were identified in a narrative manner.

Results
=======

Study selection
---------------

Our search retrieved 5159 articles from the four electronic databases searched. Following searching through the title, abstract, and full text screening, 50 articles were selected and included for data extraction and quality assessment ([Figure 1](#f1-jmdh-6-169){ref-type="fig"}). The strength of agreement between two independent raters on abstract screening was substantial (Kappa = 0.65; 95% confidence interval \[CI\] 0.53, 0.76; *P* \< 0.001), and almost perfect for full text screening (Kappa = 0.94; 95% CI 0.85, 1.00; *P* \< 0.001). Agreement was also substantial for the quality assessment using the modified OQAQ/AMSTAR checklist (Kappa = 0.63; 95% CI 0.42, 0.85; *P* \< 0.001).

Study characteristics
---------------------

Forty-one studies (82.0%) assessed RCTs using the CONSORT Statement, five (10.0%) studies used the QUOROM checklist, and two studies (4.0%) used the PRISMA tool. The final three systematic reviews (6.0%) consisted of two reviews assessing both RCTs and observational studies using the CONSORT and STROBE guidelines, and the last study used both the QUOROM and PRISMA guidelines. The systematic reviews were published in a wide variety of journals and were led by authors from many different countries ([Table 1](#t1-jmdh-6-169){ref-type="table"}). The median and interquartile range of the number of studies included in each review were 78 and 80.5, respectively.

Adherence to reporting guideline
--------------------------------

The adherence of the studies included in the systematic reviews to their respective guidelines, and the author's conclusions, are shown in [Table 2](#t2-jmdh-6-169){ref-type="table"}. Forty-three (86.0%) of the included studies concluded that the adherence to reporting guidelines was inadequate, poor, medium, or suboptimal, or that some improvement was needed. No combined, quantitative result was generated from the 50 systematic reviews due to differences in the measurement tools used by the individual reviews.

CONSORT Statement
-----------------

The adherence of RCTs to the CONSORT Statement was assessed with different versions of the CONSORT checklist. These checklists ranged from eight to 63 items, except for two studies that used the 212 subitem, Nelson--Moberg--Norton Expanded CONSORT instrument and the 201 subitem Nelson--Moberg Expanded CONSORT instrument. The revisions of the CONSORT Statements were usually based on the specific field of the RCT, and the applicability of the items on the CONSORT checklist to that field. For instance, Bian et al[@b43-jmdh-6-169] used a revised 63-item CONSORT checklist designed for Chinese Herbal Medicine clinical trials. In addition to the CONSORT checklist, four studies (Augestad et al,[@b44-jmdh-6-169] Balasubramanian et al,[@b45-jmdh-6-169] Kiehna et al,[@b46-jmdh-6-169] and Moher et al)[@b47-jmdh-6-169] also used the five-point Jadad instrument to assess the quality of the individual RCTs.[@b39-jmdh-6-169]

Of the 41 systematic reviews assessing RCTs reporting adherence to the CONSORT Statement, 33 (80%) of them concluded that some improvement was needed, or that the reporting quality was inadequate, poor, medium, or suboptimal ([Table 3](#t3-jmdh-6-169){ref-type="table"}). Furthermore, the authors recommended the use of the CONSORT Statement as a guideline to improve the quality of reporting of RCTs. Eight studies did not report inadequate reporting quality of RCTs. Froud et al[@b48-jmdh-6-169] concluded that cluster randomized trials in oral health had a reasonable quality. Fung et al[@b49-jmdh-6-169] reported that the overall level of reporting was acceptable and the reporting quality has improved since the creation of CONSORT and STROBE statements. Ladd et al[@b25-jmdh-6-169] also concluded that the overall reporting quality had improved since 1994 and the articles published in journals that endorse the CONSORT Statement had the highest levels of adherence to reporting guidelines. Moher et al[@b47-jmdh-6-169] only compared the quality of pediatric complementary and alternative medicine RCTs and reported 40% of the CONSORT checklist items were included in these RCTs. Montgomery et al[@b50-jmdh-6-169] evaluated the RCTs qualitatively and found that there was a varying level of reporting quality in factorial trials of complex interventions in community settings. Plint et al[@b51-jmdh-6-169] compared RCTs from CONSORT-endorsing and nonendorsing journals, and their results suggested some improvement in the quality of reporting when the CONSORT checklist is used. Wangge et al[@b52-jmdh-6-169] suggested that adherence to reporting guidelines for noninferiority trials have improved slightly since the CONSORT Statement has been published. Lastly, Zintzaras et al[@b53-jmdh-6-169] did not comment directly on an overall quality of reporting and concluded that adhering to reporting standards can ensure proper assessment of the results.

PRISMA, QUOROM, and STROBE statements
-------------------------------------

Three studies examined adherence to the PRISMA guidelines, and all concluded that the adherence of the assessed systematic reviews was poor or moderate. Ma et al[@b74-jmdh-6-169] and Willis et al[@b88-jmdh-6-169] used the 27-item PRISMA checklist to assess the level of adherence. Ma et al[@b74-jmdh-6-169] found that systematic reviews on traditional Chinese medicine published in Chinese journals had low adherence to the PRISMA checklist. Willis et al[@b88-jmdh-6-169] also concluded that adherence to the PRISMA checklist was generally poor for published meta-analyses of diagnostic tests. Weir et al[@b87-jmdh-6-169] used an integrated score consisting of both the PRISMA and QUOROM criteria and found that systematic reviews of empirical computerized provider order-entry research were only of moderate quality.

The assessment of studies' adherence to the QUOROM guideline was done with the 18-item QUOROM checklist coupled with a ten-item OQAQ checklist in three studies. Bereza et al[@b56-jmdh-6-169] and Junhua et al[@b70-jmdh-6-169] reported that there was a need to improve the quality of reporting of reviews, while Shea et al[@b82-jmdh-6-169] concluded that the quality of Cochrane musculoskeletal systematic reviews was good. Hemels et al[@b68-jmdh-6-169] used only the QUOROM checklist and they concluded that the quality of meta-analyses in studies on major depressive disorder was marginally acceptable. Vigna-Taglianti et al[@b85-jmdh-6-169] used the QUOROM checklist with a specific weighting system for each of the headings and the average score was 29.9/50. No conclusions concerning adherence were made, although the authors did recommend the use of manuals to prepare guidelines for the management of breast and colon cancers. Lastly, as described in the previous paragraph, Weir et al[@b87-jmdh-6-169] used an integrated score containing both PRISMA and QUOROM criteria.

The studies by Fung et al[@b49-jmdh-6-169] and Parsons et al[@b79-jmdh-6-169] assessed the adherence of both RCTs and observational studies to their respective guidelines. Parsons et al[@b79-jmdh-6-169] found there was a general lack of statistical rigor.

Factors associated with adherence to reporting guidelines
---------------------------------------------------------

Although we included systematic reviews assessing the adherence of research articles to four different guidelines, only systematic reviews related to the CONSORT Statement reported on the factors that were associated with adherence to the guideline ([Table 4](#t4-jmdh-6-169){ref-type="table"}). The exception was Hemel et al,[@b68-jmdh-6-169] who concluded that the overall quality of reporting of meta-analyses using the QUOROM guidelines did not significantly change over time, and that the year of publication was not associated with change in adherence. From the CONSORT-related studies, the following are the factors that were reported to be significantly associated with an increase in adherence to the CONSORT Statement or to the quality of reporting of RCTs, as well as the number of studies reporting these factors: publication in CONSORT-endorsing journals (3); declared funding source (1); high impact factor (3); industrial funding (1); multicenter studies (1); non-Chinese reports (compared to those published in mainland China) (1); number of authors (1); reporting of allocation concealment (1); reporting in a medical journal (1); reporting method of sequence generation (1); sample size (3); trial quality (1); type of intervention (pharmacologic intervention versus nonpharmacologic intervention); and year of publication (before and after CONSORT) (9). These factors are summarized in [Table 4](#t4-jmdh-6-169){ref-type="table"}. Having a positive outcome in RCTs (compared to a neutral or negative outcome) was the only factor reported to be significantly associated with a decrease in adherence to the CONSORT Statement (Spearman correlation = −0.192; 95% CI, −0.351 to −0.011).[@b55-jmdh-6-169] Other factors that reported but did not reach statistical significance for an association with adherence to the CONSORT Statement are also summarized in [Table 4](#t4-jmdh-6-169){ref-type="table"}.

Quality of included studies, measured by the modified OQAQ/AMSTAR checklist
---------------------------------------------------------------------------

The global score of each of the studies is listed in [Table 5](#t5-jmdh-6-169){ref-type="table"}. The mean global score of the 50 included studies was 16.6 ± 2.4. Twenty-one (42%) out of the 50 studies had a global score of 17 or more. The items with the lowest scores were question 5, "Was information on included and excluded studies provided?" and question 6, "Were the characteristics of included studies provided?" with only 16% and 32% of the studies reporting each of these items correctly, respectively.

Discussion
==========

We undertook a systematic scoping review of systematic reviews to investigate the adherence to reporting guidelines that included the CONSORT, PRISMA, QUOROM, TREND, MOOSE, and STROBE statements. Our systematic review included 50 studies that fulfilled our inclusion criteria, most of which originated from North American and European countries (43/50 studies). Despite the widespread acceptance of the CONSORT Statement and its subsequent extensions, the standards of reporting of clinical studies remained suboptimal. Our study showed that 86.0% of the systematic reviews included in this study concluded that there was a suboptimal quality of reporting across multidisciplinary clinical research topics using different study designs including RCTs and observational studies. The adherence of the assessed studies to reporting standards were not specific to any field of clinical research, but rather spanned across various disciplines including diagnostic procedures, interventions, cancer trials, and alternative medicine, implying the widespread lack of adherence to reporting guidelines in the medical literature. Despite the availability of guidelines and operational definitions of how to use these guidelines to improve reporting and transparency of clinical literature (including providing checklists, flow diagrams, and explicit methods of recruitment and allocation[@b12-jmdh-6-169]), the uptake of these guidelines remained low. Several shortcomings of the reporting standards of clinical literature include inadequate reporting of the methods, selective reporting of the results, or misinterpretation of the results.[@b91-jmdh-6-169] Studies have shown that the use of these guidelines was associated with better reporting of studies of acupuncture trials,[@b92-jmdh-6-169] and only minimal improvement in the adherence to reporting guidelines of studies that investigated diagnostic accuracy.[@b93-jmdh-6-169] It is possible that the lack of adherence may relate to the narrow focus of these guidelines on specific clinical areas or study designs, and therefore further guidelines need to be developed. Such new guidelines can be developed based on sets of tools and criteria, as proposed previously.[@b94-jmdh-6-169] The poor adherence to reporting guidelines seen in the clinical literature is also seen in other settings including the failure to follow the National Institute of Health guidelines for reporting sex and ethnicity in clinical trials.[@b95-jmdh-6-169] Efforts to address the gap between the standards set by the guidelines and the actual standards of the published literature are therefore needed.

The most striking observation from our study was the lack of consistency in methods of recording the adherence to the reporting guidelines, and therefore it was not possible to combine the results to provide a summary statistic. This highlights the need for a consensus statement on the reporting of methodological quality of studies addressing the adherence to CONSORT and other statements.

Despite the suboptimal adherence to reporting guidelines in most of the studies reviewed, we observed that RCTs have a better adherence to reporting standards than non-RCTs. In addition, studies published in journals endorsing the CONSORT Statement have higher adherence to reporting standards. Not surprisingly, studies published after the introduction of CONSORT showed a better reporting quality and adherence to reporting guidelines. These findings are encouraging and provide a platform to disseminate knowledge generated by this study to multiple disciplines in health research to stress the need for improvement in adherence to reporting guidelines.

The strengths of our study are that we conducted a rigorous systematic review and included studies investigating the quality of reporting across various clinical areas of research, thus adding a scoping review methodology to a systematic review. We have also extracted relevant data and attempted to provide a summary statistic; however, the diversity of the findings did not allow for the computation of results.

Our study results are limited by the lack of reviews addressing adherence standards to other guidelines (MOOSE, TREND, QUOROM), the inability to combine the overall study findings, and the unavailability of tools designed to assess the quality of systematic reviews investigating methodological quality. Furthermore, the design, conduct, analysis, and reporting of the results of the reviews including definitions of outcomes (and predictor variables) varied substantially within and between the guidelines. This is mainly due to the lack of an established framework or standard for the conduct and reporting of reviews assessing the adherence to guidelines.

The study findings are nonetheless important for educators, authors, editors, sponsors, health consumers, and research ethics boards.

Summary and recommendations
---------------------------

Factors that are associated with reporting standards can be grouped into four categories:

-   Study design: Better reporting standards were seen in studies with large sample sizes; RCT design; transparency in reporting randomization, adverse events, and secondary outcomes; and studies of drug interventions.

-   Timing of publication: Studies that were published more recently were associated with better quality of reporting.

-   Study sponsor: Studies with an industrial sponsor were also associated with a better quality of reporting.

-   Journal: Journals with a high impact factor and those endorsing the CONSORT Statement and its extensions tended to publish studies with better adherence to reporting standards.

Recommendations for educators
-----------------------------

Educators are at the forefront of teaching research methodology and applications in clinical settings, and therefore they play an important role in improving the reporting standards of clinical literature. Educators need to emphasize the importance of reporting standards and incorporate the guidelines in research training. They also need to provide ongoing training through workshops at professional meetings, and highlight the factors shown to improve the quality of reporting to foster improved reporting standards of the clinical literature.

Recommendations for authors
---------------------------

Authors should use the reporting standards appropriate to the study design as a guide to planning and reporting studies, and provide a flow diagram and checklist that will not only improve the reporting standard and adherence to guidelines, but will also help with transparency and reproducibility of the study. The use of the guidelines will also help to minimize reporting bias. For resources on using reporting standards, see the EQUATOR Network website.[@b12-jmdh-6-169]

Recommendations for editors
---------------------------

Studies published in journals endorsing the CONSORT and its extensions were described as having better reporting quality and increased adherence to guidelines. Therefore, editors must endorse the reporting standards as part of their journal editorial policy.

Furthermore, inclusion of the respective guideline checklist must also be part of the editorial policy. Editors need to consider assessing the adherence to reporting guidelines as a requirement for peer review, and they should revise the peer review process to incorporate these assessments.

Recommendations for sponsors
----------------------------

Sponsors can ensure that the quality of the study methodology and transparency are meeting these standards by requesting adherence to the respective reporting guidelines appropriate for the study design.

Recommendations for research ethics boards
------------------------------------------

Institutional Review Boards or Research Ethics Boards have a substantial responsibility to ensure ethical and sound methodological quality of clinical studies. Therefore, we recommend that Institutional Review Boards/Research Ethics Boards require that protocols be submitted for ethical approval to clearly state what reporting standards the study will be using based on the study design, and that reporting guidelines checklist are part of the application for ethics approval.

Recommendation for health consumers
-----------------------------------

In accordance with the general principles of evidence-based health care practice,[@b96-jmdh-6-169] we encourage consumers or health care users to be actively involved in their health care by discussing their care options with their providers. Understanding information presented in published studies can be an important ingredient in these discussions. We suggest that health care users consider the evaluation of the quality of the information presented in the literature by looking for a guideline statement and a checklist to ensure the study reporting followed a certain standard that is appropriate for the particular study design.

Lastly, one element that all parties need to take into consideration is the importance of conducting large studies. Large studies have been shown to have a better quality of reporting.[@b81-jmdh-6-169],[@b84-jmdh-6-169],[@b97-jmdh-6-169] Large studies are also less prone to problems of bias and have better precision.

Conclusion
==========

Reporting guidelines help to improve the quality and transparency of clinical studies and allow for systematic reviews and meta-analyses to provide evidence worthy of changing practice, improving knowledge, and better management of health and disease. The current reporting standards and adherence to guidelines are poor and are in need of major improvement. Steps need to be taken by all involved in the conducting and reporting of clinical research in order to achieve better standards of reporting, thus minimizing bias and providing reproducible studies that can be combined to reach conclusive evidence.
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###### 

Characteristics of included studies

  First author                       Year   Journal                                                   City/country                            Statement assessed   Number of studies
  ---------------------------------- ------ --------------------------------------------------------- --------------------------------------- -------------------- -------------------
  Al-Namankany[@b54-jmdh-6-169]      2009   International Journal of Pediatric Dentistry              London, UK                              CONSORT              173
  Areia[@b21-jmdh-6-169]             2009   Endoscopy                                                 Coimbra, Portugal                       CONSORT              120
  Augestad[@b44-jmdh-6-169]          2012   Journal of the American Medical informatics Association   Tromso, Norway                          CONSORT              32
  Balasubramanian[@b45-jmdh-6-169]   2006   Annals of Surgery                                         Sheffield, UK                           CONSORT              69
  Bath[@b55-jmdh-6-169]              1998   Stroke                                                    London, UK                              CONSORT              114
  Bereza[@b56-jmdh-6-169]            2008   Annals of Pharmacotherapy                                 Toronto, ON, Canada                     QUOROM               16
  Bian[@b43-jmdh-6-169]              2006   Journal of Chinese Integrative Medicine                   Hong Kong, People's Republic of China   CONSORT              66
  Bousquet[@b57-jmdh-6-169]          2010   Journal of Allergy and Clinical Immunology                Montpelier, France                      CONSORT              94
  Capili[@b58-jmdh-6-169]            2010   Clinical Journal of Pain                                  New York, NY, USA                       CONSORT              10
  Cavadas[@b59-jmdh-6-169]           2011   International Urogynecology Journal                       Porto, Portugal                         CONSORT              41
  Chowers[@b60-jmdh-6-169]           2009   Journal of Antimicrobial Chemotherapy                     Kfar Saba, Israel                       CONSORT              49
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###### 

Description of the studies' findings

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Guideline                                                             First author                                                                                                                                                                                                                          Measure of quality                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Results mean (SD)/% count                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Authors' conclusion
  --------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------
  CONSORT                                                               Al-Namankany[@b54-jmdh-6-169]                                                                                                                                                                                                         Modified 34-item CONSORT checklist                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Compliance varied across items and articles. Good compliance of articles to CONSORT for introduction sections (96%--98%), discussion sections (96%--98%). Poor reporting in randomization methods (5%--9%), description of sample size calculation (4%), intention-to-treat analysis (1%)                                                                                                                                                                                                                                                                                                                            Quality of reporting of RCTs in pediatric dental journals was generally poor, with negligible improvement after the publication of CONSORT Statement

  Areia[@b21-jmdh-6-169]                                                Application of CONSORT/STARD                                                                                                                                                                                                          15.7 (2.2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Level of adherence is medium for quality of reporting in diagnostic endoscopy                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Augestad[@b44-jmdh-6-169]                                             CONSORT adherence, Jadad                                                                                                                                                                                                              30.75 (4), 40% of the trials had a Jadad score of ≥3 points                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Level of adherence is low for quality of reporting for RCTs of disease specific clinical decision support                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Balasubramanian[@b45-jmdh-6-169]                                      Modified CONSORT score, allocation concealment as assessed by Schulz et al, Jadad score                                                                                                                                               Medians of the modified CONSORT score were 85.45 (interquartile range 81.09--86.13) and interquartile range 68.97 (62.89--73.1 1) for RCTs from medical and surgical journals, respectively; 13% clearly explained allocation concealment; 37.7% of RCTs had a Jadad score of ≥ 3                                                                                                                                                                                                                                                                                                                                                                                                                                                    Quality of reporting of surgical RCTs was suboptimal, and reporting in surgical journals was inferior to surgical trials in medical journals\                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   "We found that the quality of reporting of general surgical RCTs leaves considerable room for improvement"                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Bath[@b55-jmdh-6-169]                                                 In all, 33 criteria of the CONSORT Statement and 53 additional factors relevant to acute stroke or trials in general. Trial quality was also assessed with a seven-point scale                                                        Median total report quality was 40/86 (range 15--61). Median CONSORT criterion was 19/33 (9--29)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Poor quality for acute stroke RCTs\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   "We believe that authors should follow the CONSORT guidelines and that referees and editors should ensure this happens"                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Bian[@b43-jmdh-6-169]                                                 63-item revised CONSORT checklist designed for Chinese Herbal Medicine clinical studies                                                                                                                                               Median score of overall reporting quality was 32% (8%)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Overall quality of reporting of CHM RCTs was poor. Need to improve reporting in clinical trials in this area. "To improve the quality of reporting of RCTs of CHM, we recommend adopting a revised CONSORT checklist that includes items specific to CHM. We also recommend that editors of CHM journals require authors to use a structured approach to presenting their trials as a condition of publication"                                                                                                                                                                                                      

  Bousquet[@b57-jmdh-6-169]                                             Reporting of procedure, randomization, dropouts, strict conduct of intention-to-treat analysis, sample size calculation, which was assessed with eight items of the CONSORT Statement                                                 Four of the 94 studies met the eight items of the CONSORT Statement criteria                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         RCTs in subcutaneous immunotherapy and sublingual immunotherapy had poor reporting quality. Encourage more use of CONSORT Statement                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Capili[@b58-jmdh-6-169]                                               Adherence to CONSORT/presence of harms guidelines in RCTs                                                                                                                                                                             I7(range: 14--21) for CONSORT; 7/22 = 77.3% for harm                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Level of adherence is bad for quality of reporting, for RCTs on acupuncture, for pain reduction                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Cavadas[@b59-jmdh-6-169]                                              A 25-item 2010 revised CONSORT Statement                                                                                                                                                                                              No combined data: only a few items were reported in less than 50% of the studies; some items were reported in more than 90% of the studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           "RCTs in \[pelvic organ prolapsed\] are scarce. The quality of reporting is suboptimal in many aspects and has not improved in recent years"                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Lu[@b73-jmdh-6-169]                                                   Percentage of articles that reported each applicable item of the CONSORT checklist                                                                                                                                                    Sample size: only one (2.2%) of the papers mentioned sample size calculation. Randomization: 12 studies (26.1 %) were deemed to have authentic randomization. Blinding: 36 papers (78.3%) provided no information about blinding of either participants or investigators. Reporting of baseline characteristics: 39 papers (84.8%) reported the details of the baseline characteristics of participants. Length of follow-up: 22 papers (47.8%). There was no information provided on the length of time for which participants were followed. Loss-to-follow-up: a total of 36 studies (78.3%) failed to report dropout rates. Statistical reporting: only one paper (2.2%) did not report what statistical methods they had used   Findings indicate that the reporting quality of RCTs needs improvement for RCTs on the treatment of cancer pain in People's Republic of China                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Chowers[@b60-jmdh-6-169]                                              CONSORT guidelines for adverse events, adjusted to the design of the HAART trial                                                                                                                                                      No combined score: harms were reported in only 24% of trials, 1/49 reported on adverse events collection method                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Large variability and a lack of standard reporting of adverse events between trials; many trials did not adhere to CONSORT recommendations                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  de Vries[@b62-jmdh-6-169]                                             Adequate reporting of adverse drug reactions                                                                                                                                                                                          Mean of 3, and 18% of articles scored 6 or higher                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Insufficient reporting quality in adverse event reporting in RCTs of children                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Ethgen[@b63-jmdh-6-169]                                               CLEAR NPT -- a checklist to evaluate RCTs of nonpharmacological treatments                                                                                                                                                            Most studies failed to report 8/12 quality indexes in the checklist. Reporting of generation of allocation sequence was adequate in 38.8% of studies, treatment allocation in 26.3%, intention-to-treat analysis in 70.0%                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Inadequate reporting amongst trials involving stents. "The current reporting of results of RCTs testing stents needs to be improved to allow readers to appraise the risk of bias and the applicability of the results"                                                                                                                                                                                                                                                                                                                                                                                              

  Eyawo[@b64-jmdh-6-169]                                                Revised CONSORT checklist to assess reporting of each items on the checklist in counts (percentage)                                                                                                                                   14/16 items ranged from 2%--7%; the other two items, sample size determination, and reporting of masking were reported in 72% and 75% of the articles                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Deficiencies in the design, planning, and reporting of noninferiority and equivalence trials in ophthalmology literature                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Farrokhyar[@b64-jmdh-6-169]                                           Modified CONSORT Statement and added factor relevant to surgical trials and CABG surgery                                                                                                                                              51.7 out of 105 (11.5)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               The total reporting quality of trials in this review varied substantially between publications (35--96 out of a possible max score of 105). The results showed that there is a need for improvement in quality of reporting                                                                                                                                                                                                                                                                                                                                                                                          

  Froud[@b48-jmdh-6-169]                                                Number and percentage of studies satisfying the revised 1l-item consort checklist                                                                                                                                                     Most items were reported in an adequate percentage of studies; 5/11 reported in 78%--100% of the studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Their results suggest that cluster randomized trials in oral health are of reasonable quality with respect to the key criteria of accounting for clustering in the design and analysis                                                                                                                                                                                                                                                                                                                                                                                                                               

  Fung[@b49-jmdh-6-169] (CONSORT and STROBE) Gagnier[@b66-jmdh-6-169]   Presence or absence of CONSORT (maximum score of 37 points) statement indicators Mean CONSORT score based on 42 items and the percentage of items reported                                                                            CONSORT: median and mean values of 89% and 83%, respectively\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Overall level of reporting is acceptable and has improved since the creation of CONSORT and STROBE\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                              18.92 out of 42 (5.54), and 45% of items were reported across all trials                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             "We found that reports of RCTs of herbal medicine interventions reported less than half of the necessary information in their published results" Overall adherence is low                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Halpern[@b67-jmdh-6-169]                                              Percentage of articles that reported each applicable item of the modified CONSORT checklist and count of articles complying with modified CONSORT items                                                                               In the 23 articles in Anesthesia and Analgesia, the median percentage of correct CONSORT items was 63%                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Poor -- total number of items that are inadequately reported is high in the current RCT literature with obstetric anesthesia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Herdan[@b69-jmdh-6-169]                                               22-item CONSORT checklist expressed                                                                                                                                                                                                   On average 87.4% of the CONSORT items were reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  The reporting quality has improved significantly in the period after dissemination of the CONSORT Statement; however, reporting of adverse events needs attention                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  Kiehna[@b46-jmdh-6-169]                                               Quality of reporting score using CONSORT (max score of 44) and Jadad score out of 5 points                                                                                                                                            26.4 out of 44 (range: 17--38)/67% of studies had no description or the prestudy sample size calculation, 63% did not describe whether subjects, treatment providers or assessors/analysts were blinded                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              The quality of reporting of RCTs in neurosurgical journals remains suboptimal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Kober[@b71-jmdh-6-169]                                                CONSORT criteria based on a 14-item questionnaire                                                                                                                                                                                     75% of studies reported only six of the 13 items; only 14% reported\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Articles of Hodgkin's lymphoma published after 1996 do not conform to the CONSORT recommendations                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                              randomization process; only 13% provided details about concealment of allocation; only 13% provided a statement on study power; only 12% used intention-to-treat analysis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Ladd[@b25-jmdh-6-169]                                                 Assessment of 36 of the items from the CONSORT Statement based on a score out of 36                                                                                                                                                   24.43 out of 36 (3.27)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               The overall level of adherence to CONSORT has improved since 1994, and continues to remain highest among studies that have been published within journals that have adopted the CONSORT guidelines                                                                                                                                                                                                                                                                                                                                                                                                                   

  Li[@b72-jmdh-6-169]                                                   Score out of 40 based on a 40-item modified checklist based on the CONSORT Statement                                                                                                                                                  42% of the studies included explained how sample size was determined; 14% of studies described whether or not outcome assessors were blinded                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         The reporting quality of these trials is suboptimal and substantial improvement is required to meet the CONSORT guidelines. Almost 50% of the trials we reviewed did not satisfy more than half of the criteria in the modified CONSORT checklist, and only 23% of RCTs provided adequate details of Tai Chi intervention used in the trials                                                                                                                                                                                                                                                                         

  Marshman[@b75-jmdh-6-169]                                             56 criteria based on the CONSORT Statement                                                                                                                                                                                            27/56, with variation between journals (23.2 to 27.7)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Poor adherence to the CONSORT checklist in RCTs in dental health                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Moberg-Mogren[@b76-jmdh-6-169]                                        Average NMECI score (0--201 subitems scale)                                                                                                                                                                                           104.2(32.9)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Less than half of the articles met criteria of these subitems in selected RCTs relevant to occupational therapy                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Moher[@b47-jmdh-6-169]                                                CONSORT checklist, frequency of unclear allocation concealment, and a five-point quality assessment instrument (Jadad)                                                                                                                12.7/32 of the CONSORT checklist included; 81.3% unclear allocation concealment; 1.9/5 for the Jadad assessment scale                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Overall, there was no difference in the PedCAM RCTs and conventional medicine quality, with both types achieving 43% of their maximum possible outcome                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Montané[@b77-jmdh-6-169]                                              Revised CONSORT checklist, 22 items                                                                                                                                                                                                   10.5(2.7)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Quality was good in 23 (25%) of the articles and poor in 69 (75%) of the reports for RCTs on the efficacy of analgesic drugs in postoperative pain after TOS                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Montgomery[@b50-jmdh-6-169]                                           Qualitative look                                                                                                                                                                                                                      N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Varying level of reporting quality factorial trials of complex interventions in community settings                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Norton-Mabus[@b78-jmdh-6-169]                                         NMNECI (2l2subitems)                                                                                                                                                                                                                  119.5(25.48)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Article consistency with CONSORT Statement was less than 60%. Occupational therapy RCT had higher consistency with the instrument, scoring higher than articles in speech therapy                                                                                                                                                                                                                                                                                                                                                                                                                                    

  Parsons[@b79-jmdh-6-169] (combined CONSORT and STROBE guideline)      Overall compliance calculated as the weighted mean of the compliance rates for the seven selected journals, using a previously made questionnaire                                                                                     59% (CONSORT)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Very few papers fulfilling all criteria; general lack of statistical rigor                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Piggott[@b80-jmdh-6-169]                                              Compared RCTs of three different time period cohorts, with the CONSORT (condensed, 13-item) checklist                                                                                                                                 Quality of reporting variable; 30% of trials or less used true randomization, allocation concealment, intention-to-treat analysis, and power calculations                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Quality of reporting over time cohorts was variable, no consistent improvement over time. Quality of reporting remains poor for RCTs in specialized palliative care literature                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Plint[@b51-jmdh-6-169]                                                22-item checklist from the CONSORT Statement                                                                                                                                                                                          Standardized mean difference between CONSORT-adopting journals and nonadopters was 0.83 (95% CI, 0.46--1.19)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Journal adoption of CONSORT is associated with improved reporting of RCTs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Rios[@b81-jmdh-6-169]                                                 Overall quality score, which is a 15 point overall reporting quality score made from CONSORT checklist                                                                                                                                10(2.03)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Suboptimal reporting quality in an endocrine journal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Strech[@b83-jmdh-6-169]                                               A checklist based on the CONSORT Statement                                                                                                                                                                                            There are 72 items on the checklist; 42% were reported adequately and 25% were reported inadequately                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 While some trial-related information is well reported, a good part of the reporting quality of RCTs in bipolar disorder falls well below the required and practically feasible level for many aspects essential for the adequate interpretation of methodological quality and clinical relevance. Authors should be further encouraged to follow the CONSORT criteria. No consistent trend could be shown for improvement in the quality of reporting over time, or for reporting essential methodological items differently. There is a consistent trend toward better reporting in journals that endorse the URM   

  Thabane[@b84-jmdh-6-169]                                              Percentage of studies satisfying each of the 44 CONSORT criteria                                                                                                                                                                      26.25 (4.51 ) and 60% adherence for reporting criteria: 90% satisfied criteria for the introduction; 19% for the methods; 75% the study protocol, 70% for the results                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Overall, the quality of reporting is suboptimal in RCTs of weight loss intervention. Key reporting criteria that may impact the validity and generalizability of the results were adequately reported                                                                                                                                                                                                                                                                                                                                                                                                                

  Walleser[@b86-jmdh-6-169]                                             CONSORT-CRT                                                                                                                                                                                                                           34% inadequately reporting on more than half of the CONSORT-CRT criteria                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             The quality of reporting in CRTs needs improvement. This will hopefully improve implementation and planning                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Wangge[@b52-jmdh-6-169]                                               Extension of the CONSORT Statement for noninferiority and equivalence trial                                                                                                                                                           No blinding in 34.0%, noninferiority margin in 97.8%, with only 45.7% reporting the method of determining the margin                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Adherence improved slightly after CONSORT for noninferiority trials                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Zhong[@b89-jmdh-6-169]                                                Number of studies describing each of the 38 modified consort items                                                                                                                                                                    Of the 38 CONSORT items, only five items were described in more than 80% of the 153 included                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Adherence was suboptimal for two-group parallel randomized controlled clinical trials of multiherb formulae                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Zintzaras[@b53-jmdh-6-169]                                            17-item CONSORT checklist                                                                                                                                                                                                             17 CONSORT checklist items were reported in 7/18 studies, and 9/17 CONSORT checklist items were reported in all 18/18 studies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Proper assessment of the credibility and generalizability of the results can be ensured by reporting quality                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Ziogas[@b50-jmdh-6-169]                                               24-item questionnaire based on the CONSORT checklist                                                                                                                                                                                  75% of the studies addressed 13 out of the 24 items of the CONSORT Statement                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Reporting on myeloid malignancies remains unsatisfactory and requires further improvement to properly assess the validity of clinical research                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  PRISMA                                                                Ma[@b74-jmdh-6-169]                                                                                                                                                                                                                   Adherence to PRISMA checklist items (27 items)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Title, introduction, limitations, and conclusions were reported well in 90% or more of the studies. Most other items varied from 30%--70% of the studies                                                                                                                                                                                                                                                                                                                                                                                                                                                             Compliance with PRISMA reporting guidelines is low for systematic reviews on TCM published in Chinese journals

  Weir[@b87-jmdh-6-169] (combined PRISMA and QUOROM guideline)          An integrated score consisting of the number of items completed over the total numbers of items on both the PRISMA and QUOROM criteria, resulting in cored ranking from 0% to 100% (excluding the items focused on in the abstract)   Mean = 63% (range 45%--81%) on a scale of 0%--100%                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Systematic reviews of empirical computerized provider order-entry research had moderate quality                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Willis[@b88-jmdh-6-169]                                               Adherence to the 27-item PRISMA checklist                                                                                                                                                                                             Of the 236 meta-analyses included following selection: 1% reported the study protocol; 25% reported the searches used; 32% reported the results of a risk of bias assessment; and 35% reported the abstract as a structured summary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Compliance with the PRISMA statement was generally poor; none of the review completely adhered to all 27 checklist items for the published meta-analyses of diagnostic tests                                                                                                                                                                                                                                                                                                                                                                                                                                         

  QUOROM                                                                Bereza[@b56-jmdh-6-169]                                                                                                                                                                                                               18-item QUOROM checklist, ten-item checklist OQAQ used for scientific quality                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        61% ± 19% (median 60%, range 39%--94%) for the QUOROM checklist. 58% ± 28% for OQAQ                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  "Reporting/scientific quality was considered less than fair-to-good. Stakeholders should strive for higher scientific quality of meta-analyses"

  Hemels[@b68-jmdh-6-169]                                               18-item QUOROM checklist                                                                                                                                                                                                              On average 50.2% of the CONSORT items were reported                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  The overall quality of reporting in the meta-analysis of RCTs in major depressive disorder was marginally acceptable                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Junhua[@b70-jmdh-6-169]                                               18-item QUOROM checklist, ten-item checklist OQAQ used for scientific quality                                                                                                                                                         No combined score; methodological and reporting flaws in more than half of the review articles. Flaws were mainly in the literature search, characteristics of included and excluded studies, quality assessment of primary trials, and data merging                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Methodology and reporting quality are poor in both systematic reviews and meta-analysis of TCM published in journals in the People's Republic of China                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Shea[@b82-jmdh-6-169]                                                 18-item QUOROM checklist, ten-item checklist OQAQ used for scientific quality                                                                                                                                                         All systematic reviews were found to have good overall quality. OQAQ mean score was 5.02 (95% CI 3.71--6.32)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Reporting quality of Cochrane musculoskeletal systematic reviews was generally good, with room for improvement                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Vigna-Taglianti[@b85-jmdh-6-169]                                      QUOROM-based checklist (score out of 50)                                                                                                                                                                                              29.9/50                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              "Oncologists should be aware that they could be relying on poor underlying documents. Writing groups should be aware of methodological problems, and should consult the existing manuals for the preparation of guidelines"                                                                                                                                                                                                                                                                                                                                                                                          

  Weir[@b87-jmdh-6-169] (combined PRISMA and QUOROM guideline)          An integrated score consisting of the number of items completed over the total numbers of items on both the PRISMA and QUOROM criteria, resulting in cored ranking from 0% to 100% (excluding the items focused on in the abstract)   63% (range 45%--81%) on a scale of 0%--100%                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Systematic reviews of empirical computerized provider order-entry research were of moderate quality                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  STROBE                                                                Cook[@b61-jmdh-6-169]                                                                                                                                                                                                                 Quality of reporting, methodological quality, and the association between methodological quality and effect size                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     253 (90)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Reporting the quality of experimental research on health profession education was found to be generally suboptimal

  Fung[@b45-jmdh-6-169] (combined CONSORT and STROBE guideline)         STROBE (maximum score of 37 points) statement indicators                                                                                                                                                                              STROBE mean and median: 70% and 71%, respectively                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Overall level of reporting is acceptable and has improved since the creation of CONSORT and STROBE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Parsons[@b79-jmdh-6-169] (combined CONSORT and STROBE guideline)      Weighted mean of the compliance rates for the seven selected journals, using a previously made questionnaire                                                                                                                          58% (strobe)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Very few papers fulfilling all criteria, general lack of statistical rigor                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** SD, standard deviation; CONSORT, Consolidated Standards of Reporting Trials; RCT, randomized controlled trial; CHM, Chinese herbal medicine; HAART, highly active antiretroviral treatment; CLEAR NPT, checklist to evaluate a report of a nonpharmacological trial; CABG, coronary artery bypass surgery; STROBE, Strengthening the Reporting of Observational Studies in Epidemiology; NMECI, Nelson-Moberg Expanded CONSORT Consolidated Standards of Reporting Trials Instrument; PedCAM, Pediatric Complementary and Alternative Medicine Research and Education Network; TOS, thoracic outlet syndrome; N/A, not applicable; NMENCI, Nelson-Moberg, Norton Expanded Consolidated Standards of Reporting Trials Instrument; CI, confidence interval; URM, uniform requirement for manuscript; CRT, consolidated standard of reporting trial; NI, noninferiority; PRISMA, preferred reporting items for systematic reviews and meta-analyses; QUOROM, Quality of Reporting of Meta-analysis; OQAQ, Overview Quality Assessment Questionnaire; TCM, traditional Chinese medicine.

###### 

Studies' conclusions

  Type of guideline   Total number of studies                                 Number of studies concluding that "some improvements are needed, reporting inadequate, poor, medium, suboptimal, etc"
  ------------------- ------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  CONSORT             41 (two combined study with both CONSORT and STROBE)    33 (80%)[@b21-jmdh-6-169],[@b43-jmdh-6-169]--[@b46-jmdh-6-169],[@b54-jmdh-6-169],[@b55-jmdh-6-169],[@b57-jmdh-6-169]--[@b60-jmdh-6-169],[@b62-jmdh-6-169]--[@b67-jmdh-6-169],[@b69-jmdh-6-169],[@b71-jmdh-6-169]--[@b73-jmdh-6-169],[@b75-jmdh-6-169]--[@b81-jmdh-6-169],[@b83-jmdh-6-169],[@b84-jmdh-6-169],[@b86-jmdh-6-169],[@b89-jmdh-6-169],[@b90-jmdh-6-169]
  PRISMA              3 (one combined study with both PRISMA and QUOROM)      3 (100%)[@b74-jmdh-6-169],[@b87-jmdh-6-169],[@b88-jmdh-6-169]
  QUOROM              6 (one combined study with both PRISMA and QUOROM)      3 (50%)[@b56-jmdh-6-169],[@b70-jmdh-6-169],[@b87-jmdh-6-169]
  STROBE              3 (two combined studies with both CONSORT and STROBE)   2 (67%)[@b61-jmdh-6-169],[@b79-jmdh-6-169]
  All guidelines      50 (distinct studies)                                   43 (86.0%)[@b21-jmdh-6-169],[@b43-jmdh-6-169]--[@b46-jmdh-6-169],[@b54-jmdh-6-169]--[@b67-jmdh-6-169],[@b69-jmdh-6-169]--[@b81-jmdh-6-169],[@b83-jmdh-6-169],[@b84-jmdh-6-169],[@b86-jmdh-6-169]--[@b90-jmdh-6-169]

**Abbreviations:** CONSORT, Consolidated Standards of Reporting Trials; STROBE, Strengthening the Reporting of Observational Studies in Epidemiology; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; QUOROM, Quality of Reporting of Meta-analysis.

###### 

Factors associated with reporting quality of articles using the CONSORT guideline

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  First author                       Sample size   Factors associated with adherence ↑↓
  ---------------------------------- ------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Al-Namankany[@b54-jmdh-6-169]      173           1\. Year of publication [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}

  Areia[@b21-jmdh-6-169]             120           1\. Publication in CONSORT-endorsing journals [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}\
                                                   2. Year of publication [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}

  Balasubramanian[@b45-jmdh-6-169]   69            1\. Number of authors [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}\
                                                   2. Multicenter studies [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}\
                                                   3. Declared funding source [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}\
                                                   4. Reporting in medical journals [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}

  Bath[@b55-jmdh-6-169]              114           1\. Trial quality [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}\
                                                   2. Trials with positive outcome [(↓)](#tfn6-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}\
                                                   3. Year of publication [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}

  Capili[@b58-jmdh-6-169]            10            1\. Journal requiring the use of CONSORT [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}

  Chowers[@b60-jmdh-6-169]           49            1\. Industry sponsored trials (industry sponsored versus nonindustry sponsored trial) [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}\
                                                   2. Year of publication [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}

  de Vries[@b62-jmdh-6-169]          107           1\. Sponsoring [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}

  Ethgen[@b63-jmdh-6-169]            132           1\. Impact factor [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}\
                                                   2. Publication in CONSORT-endorsing journals [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}

  Farrokhyar[@b65-jmdh-6-169]        50            1\. Sample size [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}\
                                                   2. Year of publication (more recent publication year \[up to 2005\] \[2001, *P* = 0.822; 2002, *P* \< 0.001; 2003, *P* = 0.204; 2004, *P* \< 0.001; 2005, *P* \< 0.001\])\
                                                   3. Location of the study (UK, *P* = 0.900; Scandinavia, *P* = 0.002; Other, *P* = 0.003)\
                                                   4. Source of funding [(↓)](#tfn6-jmdh-6-169){ref-type="table-fn"}\
                                                   5. Type of primary outcome in the study-categorical [(↓)](#tfn6-jmdh-6-169){ref-type="table-fn"}

  Herdan[@b69-jmdh-6-169]            37            1\. Year of publication [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}

  Kiehna[@b46-jmdh-6-169]            27            1\. Publication in CONSORT-endorsing journals [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}

  Ladd[@b25-jmdh-6-169]              127           1\. Year of publication [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}

  Moberg-Mogren[@b76-jmdh-6-169]     14            1\. Year of publication [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}

  Montané[@b77-jmdh-6-169]           92            1\. Year of publication [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}\
                                                   2. Impact factor [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}\
                                                   3. Studies with placebo control group [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}

  Montgomery[@b50-jmdh-6-169]        76            1\. Year of publication [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}

  Plint[@b51-jmdh-6-169]             8             1\. Reporting method of sequence generation [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}\
                                                   2. Allocation concealment [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}\
                                                   3. Overall consort items [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}

  Rios[@b81-jmdh-6-169]              89            1\. Industrial funding [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}\
                                                   2. Journal of publication (publication in JCEM) [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}\
                                                   3. Sample size [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}

  Thabane[@b84-jmdh-6-169]           63            1\. Sample sizes [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}\
                                                   2. Year of publication [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}\
                                                   3. Type of intervention (pharmacologic intervention versus nonpharmacologic intervention) [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}

  Zhong[@b89-jmdh-6-169]             153           1\. Non-Chinese reports (compared to those published in mainland China) [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}\
                                                   2. Publication in CONSORT-endorsing journals [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}

  Ziogas[@b90-jmdh-6-169]            261           1\. Year of publication [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}\
                                                   2. Impact factor [(↑)](#tfn5-jmdh-6-169){ref-type="table-fn"}[\*](#tfn4-jmdh-6-169){ref-type="table-fn"}
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:**

Statistically significant increase/decrease, *P* ≤ 0.05;

positively associated with adherence;

negatively associated with adherence.

**Abbreviations:** CONSORT, Consolidated Standards of Reporting Trials; JCEM, The Journal of Clinical Endocrinology and Metabolism.

###### 

Reporting quality of the 50 included systematic reviews, assessed by the modified AMSTAR/OQAQ (ten items, score out of 20)

  First author                       Global score
  ---------------------------------- --------------
  Al-Namankany[@b54-jmdh-6-169]      15
  Areia[@b21-jmdh-6-169]             18
  Augestad[@b44-jmdh-6-169]          20
  Balasubramanian[@b45-jmdh-6-169]   16
  Bath[@b55-jmdh-6-169]              16
  Bereza[@b56-jmdh-6-169]            20
  Bian[@b43-jmdh-6-169]              15
  Bousquet[@b57-jmdh-6-169]          18
  Capili[@b58-jmdh-6-169]            15
  Cavadas[@b59-jmdh-6-169]           17
  Lu[@b73-jmdh-6-169]                18
  Chowers[@b60-jmdh-6-169]           12
  Cook[@b61-jmdh-6-169]              18
  de Vries[@b62-jmdh-6-169]          14
  Ethgen[@b63-jmdh-6-169]            13
  Eyawo[@b64-jmdh-6-169]             18
  Farrokhyar[@b65-jmdh-6-169]        19
  Froud[@b48-jmdh-6-169]             16
  Fung[@b49-jmdh-6-169]              17
  Gagnier[@b66-jmdh-6-169]           16
  Halpern[@b67-jmdh-6-169]           14
  Hemels[@b68-jmdh-6-169]            19
  Herdan[@b69-jmdh-6-169]            15
  Junhua[@b70-jmdh-6-169]            13
  Kiehna[@b46-jmdh-6-169]            16
  Kober[@b71-jmdh-6-169]             17
  Ladd[@b25-jmdh-6-169]              19
  Li[@b72-jmdh-6-169]                18
  Ma[@b74-jmdh-6-169]                19
  Marshman[@b75-jmdh-6-169]          14
  Moberg-Mogren[@b76-jmdh-6-169]     16
  Moher[@b47-jmdh-6-169]             14
  Montané[@b77-jmdh-6-169]           15
  Montgomery[@b50-jmdh-6-169]        17
  Norton-Mabus[@b78-jmdh-6-169]      10
  Parsons[@b79-jmdh-6-169]           17
  Piggott[@b80-jmdh-6-169]           14
  Plint[@b51-jmdh-6-169]             18
  Rios[@b81-jmdh-6-169]              20
  Shea[@b82-jmdh-6-169]              19
  Strech[@b83-jmdh-6-169]            18
  Thabane[@b84-jmdh-6-169]           19
  Vigna-Talianti[@b85-jmdh-6-169]    15
  Walleser[@b86-jmdh-6-169]          19
  Wangge[@b52-jmdh-6-169]            12
  Weir[@b87-jmdh-6-169]              20
  Willis[@b88-jmdh-6-169]            20
  Zhong[@b89-jmdh-6-169]             17
  Zintzaras[@b53-jmdh-6-169]         18
  Ziogas[@b90-jmdh-6-169]            15

**Abbreviations:** AMSTAR, assessment of multiple systematic reviews; OQAQ, Overview Quality Assessment Questionnaire.
